Search

Search Constraints

You searched for: Author/Creator Tamaki, Shunsuke

Search Results

1. Are cardiac sympathetic nerve activity and epicardial adipose tissue associated with atrial fibrillation recurrence after catheter ablation in patients without heart failure?. (15th March 2020)

2. Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction. (24th March 2022)

3. Clinical Determinants of Quality of Life in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-Heart Failure With Preserved Ejection Fraction Registry. (21st July 2022)

4. Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction. (15th September 2022)

5. Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction. (April 2021)

6. Diastolic index as a short-term prognostic factor in heart failure with preserved ejection fraction. Issue 2 (17th December 2020)

7. Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial. Issue 2 (11th November 2020)

8. Eplerenone might affect atrial fibrosis in patients with hypertension. Issue 10 (23rd September 2017)

9. High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction. (2nd May 2021)

10. Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction. (3rd April 2020)